JB

JENNIFER BARBLAN

ABBOTT LABORATORIES · WASHINGTON, DC · registered since 2024
Registered · LDAActive

At a glance

Registered since
2024
Senate LDA system
Clients
1
last 3 years
Filings
3
9 agencies contacted
Activity
filings by quarter
Works on

Background

Career
WASHINGTON, DC
2024 - present

Specific issues

Proposals related to access to infant formula.
Agriculture · 2024 Q3
S. 1000/H.R. 1835 Saving Access to Laboratory Services Act. H.R. 1691 Ensuring Patient Access to Critical Breakthrough Products Act of 2023. Proposals regarding PAMA regulations and changes to modernize and update the Clinical Laboratory Fee Schedule. Proposals related to Medicare coverage of continuous glucose monitors. Proposals to ensure Medicare coverage for emerging medical device technology. Proposals related to medical device reimbursement and coverage.
Medicare/Medicaid · 2024 Q3
S. 2477/H.R. 1770 Equitable Community Access to Pharmacist Services Act. H.R. 2369 Verifying Accurate Leading-edge IVCT Development (VALID) Act of 2023. Proposals related to sterilization of medical devices. Proposals related to the President's Emergency Plan for AIDS Relief (PEPFAR). Proposals related to PT/INR (Prothrombin Time/International Normalized Ratio) testing. Proposals related to heart failure technology.
Health Issues · 2024 Q3
Proposals related to data privacy/data collection, usage and retention.
Consumer Issues/Safety/Products · 2024 Q2
S. 2477/H.R. 1770 Equitable Community Access to Pharmacist Services Act. H.R. 2369 Verifying Accurate Leading-edge IVCT Development (VALID) Act of 2023. Proposals related to sterilization of medical devices. Proposals related to the President's Emergency Plan for AIDS Relief (PEPFAR). Proposals related to Department of Defense coverage of continuous glucose monitors. Proposals related to future pandemic preparedness. Proposals related to the safe manufacturing of medical devices. Proposals related to telehealth implementation and remote monitoring. Proposals related to the use of diagnostic tests in CLIA-waived settings. Proposals related to federal workforce drug testing programs. Proposals related to medical device cybersecurity.
Health Issues · 2024 Q2
S. 1000/H.R. 1835 Saving Access to Laboratory Services Act. H.R.3674 Providing Relief and Stability for Medicare Patients Act of 2023. Proposals regarding PAMA regulations and changes to modernize and update the Clinical Laboratory Fee Schedule. Proposals related to Medicare coverage of continuous glucose monitors. Proposals related to outpatient coverage of cardiovascular medical devices.
Medicare/Medicaid · 2024 Q1

Clients

2024 · 3 filings
$██,███ / qtrUnlock

Filing history

2024 Q3
ABBOTT LABORATORIES
Q3lda.gov →
2024 Q2
ABBOTT LABORATORIES
Q2lda.gov →
2024 Q1
ABBOTT LABORATORIES
Q1lda.gov →
Showing recent filings · full history on lda.gov